🇸🇬 Polatuzumab in Singapore

Polatuzumab (Polatuzumab) regulatory status in Singapore.

Marketing authorisation

HSA

  • Status: likely_approved

Polatuzumab in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Oncology approved in Singapore

Frequently asked questions

Is Polatuzumab approved in Singapore?

Yes. HSA has authorised it.

Who is the marketing authorisation holder for Polatuzumab in Singapore?

National Cancer Institute (NCI) is the originator. The local marketing authorisation holder may differ — check the official source linked above.